Document ID: chunk:federal_register_of_legislation:C2016A00012:clause:1_12f
Version: federal_register_of_legislation:C2016A00012
Segment Type: clause
Provision Reference: sch 1 cl 12F
Character Range: 88535–90968

12F  Conditions that may be prescribed or imposed
  The conditions of a manufacture licence that may be prescribed or imposed may relate to, but are not limited to, the following:
 (a) matters relating to the activities authorised by the licence, including activities authorised in accordance with a permit;
 (b) the supply, delivery, dealing in any way with, transportation and disposal of drugs manufactured under the licence;
 (c) the use of names or symbols that may suggest or imply a particular effect upon humans of a drug or narcotic preparation that contains cannabis or cannabis resin, but not so as to prevent the specification of factual material;
 (d) waste disposal;
 (e) the destruction of drugs, narcotic preparations and by‑products of such drugs or preparations;
 (f) documentation and record‑keeping in respect of activities to which the licence relates;
 (g) facilities and containment in respect of the manufacture authorised by the licence, including requirements relating to the following:
 (i) the security of premises;
 (ii) the certification of premises or facilities to specified containment levels;
 (h) the safety, security and surveillance of premises;
 (i) access to land and premises on which activities authorised by the licence are, are to be, or have been undertaken;
 (j) measures to manage risks posed to the health and safety of people, or to the environment;
 (k) data collection, including studies to be conducted;
 (l) information that is to be provided, whether on request by the Secretary or on a regular basis, and the times at which, or periods within which, such information is to be provided;
 (m) the taking of samples of any thing to which the licence relates and the removal and testing of such samples;
 (n) auditing and reporting;
 (o) actions to be taken in case of loss, theft, spoilage or destruction (however occurring) of drugs manufactured, under (or purportedly under) the licence, or of narcotic preparations;
 (p) compliance with the following (however described):
 (i) a code of practice;
 (ii) a technical or procedural guideline (however described);
 (q) contingency planning;
 (r) matters relating to the employment of staff or the engagement of contractors;
 (s) advertising to the public by the licence holder in relation to drugs or narcotic preparations that contain cannabis plants, cannabis or cannabis resin;
 (t) the labelling of medicinal cannabis products.